Home | Publications | IT & eHealth place holder
place holder place holder

IT & eHealth

EDC on the Ground

User Insights and Buying Behavior

Publication Date   November 2005
Publisher   Life Science Insights
Product Type   Brief
Pages   11
ISBN Number   not applicable
Product Code   LSI020
Ask a question about this product?

Price £1,945.00

approximately: $3,902 | €2,442

Summary


This study discusses the premise that pharmaceutical and biotech organizations that adopt EDC must be willing to make investments in both technology and business process change in order to facilitate successful programs. The most compelling business drivers for the adoption of EDC include efficiency of clinical trial programs and data quality improvements. These combine with other advantages to allow companies to conclude trials sooner with EDC and — in the big picture — to potentially bring drugs to market sooner.

Content


In This Study

Situation Overview
Introduction
The Market Challenges for EDC in the Pharmaceutical Industry
The Business Case for EDC and Clinical Data Management System
Identifying the Business Problem
Table: Clinical Trial Phases

Figure: Clinical Trials EDC Adoption Now and in 12 Months
Business Drivers of EDC Adoption
EDC and CDMS Technology Solutions for the Pharmaceutical Industry
Solution Components
Figure: Clinical Trials EDC and CDMS Solutions Data Collection Process
The Decision to Purchase EDC
Table: Stakeholder Concerns in Enterprise Clinical Trial Automation System Adoption

Budget Considerations

Future Outlook

Essential Guidance
Actions to Consider

Learn More
Related Research
Acronym and Abbreviation Glossary
Synopsis